Tower Research Capital LLC (Trc) Pharma Cyte Biotech, Inc. Call Options Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PMCB
# of Institutions
29Shares Held
674KCall Options Held
13.7KPut Options Held
2.1K-
Vanguard Group Inc Valley Forge, PA195KShares$202,2980.0% of portfolio
-
Geode Capital Management, LLC Boston, MA139KShares$144,4920.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$95,7707.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$86,0360.08% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny49.5KShares$51,4800.0% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $21.6M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...